Scholar Rock Holding (SRRK) Accumulated Depreciation (2017 - 2025)
Scholar Rock Holding's (SRRK) quarterly Accumulated Depreciation came in at $14.9 million in Q4 2025, up 12.54% year-on-year from $13.2 million in Q4 2024, and up 12.54% quarter-over-quarter from $13.2 million in Q4 2024.
Scholar Rock Holding (SRRK) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Scholar Rock Holding's Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $14.9 million for Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 12.54% year-over-year to $14.9 million in Q4 2025; TTM through Dec 2025 was $14.9 million, a 12.54% increase from a year earlier, with the FY2025 full-year figure at $14.9 million, up 12.54% from the prior year.
- Accumulated Depreciation advanced to $14.9 million in Q4 2025 per SRRK's latest filing, from $13.2 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $14.9 million in Q4 2025 and bottomed at $7.3 million in Q4 2021.
- The 5-year median for Accumulated Depreciation is $11.3 million (2023), against an average of $11.4 million.
- Across the five-year window, Accumulated Depreciation surged 50.05% in 2021 and climbed 10.7% in 2023, its largest moves.
- Year by year, Accumulated Depreciation stood at $7.3 million in 2021, then surged by 40.32% to $10.2 million in 2022, then increased by 10.7% to $11.3 million in 2023, then climbed by 16.7% to $13.2 million in 2024, then advanced by 12.54% to $14.9 million in 2025.
- Per Business Quant, the three latest SRRK Accumulated Depreciation figures stand at $14.9 million (Q4 2025), $13.2 million (Q4 2024), and $11.3 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.88 Mn |
| Dec 31, 2024 | 13.22 Mn |
| Dec 31, 2023 | 11.33 Mn |
| Dec 31, 2022 | 10.23 Mn |
| Dec 31, 2021 | 7.29 Mn |
| Dec 31, 2020 | 4.86 Mn |
| Dec 31, 2019 | 3.56 Mn |
| Dec 31, 2018 | 2.36 Mn |
| Sep 30, 2018 | 2.12 Mn |
| Jun 30, 2018 | 1.91 Mn |
| Dec 31, 2017 | 1.55 Mn |